HIGH-RISK BREAST CANCER
Clinical trials for HIGH-RISK BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK BREAST CANCER trials appear
Sign up with your email to follow new studies for HIGH-RISK BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may spare breast cancer patients from chemo
Disease control Recruiting nowThis study tests whether a blood test (ctDNA) can identify women with early-stage, hormone-positive breast cancer who can safely avoid chemotherapy. Instead of chemo, they receive a targeted pill (dalpiciclib) plus hormone therapy before surgery. The goal is to reduce side effect…
Matched conditions: HIGH-RISK BREAST CANCER
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Blood test may guide breast cancer therapy, reducing chemo need
Disease control Recruiting nowThis phase 2 trial tests a personalized approach for early-stage, hormone receptor-positive breast cancer. Participants receive a combination of CDK4/6 inhibitors and endocrine therapy before surgery. A blood test (ctDNA) is used to monitor tumor DNA and may help decide if chemot…
Matched conditions: HIGH-RISK BREAST CANCER
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC